We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
SM Energy
SM
$7.67B
| – | – |
-21,276
| Closed | -$1.77M |
|
|
SNV
1002
DELISTED
Synovus
SNV
| – | – |
-2,619
| Closed | -$66K |
|
1003
Simon Property Group
SPG
$74.3B
| – | – |
-4,038
| Closed | -$578K |
|
1004
Sarepta Therapeutics
SRPT
$1.62B
| – | – |
-850,400
| Closed | -$17.3M |
|
1005
Sensata Technologies
ST
$6.89B
| – | – |
-21,033
| Closed | -$815K |
|
1006
Steel Dynamics
STLD
$36.2B
| – | – |
-104,814
| Closed | -$2.05M |
|
1007
STMicroelectronics
STM
$46.4B
| – | – |
-47,247
| Closed | -$378K |
|
1008
Seagate
STX
$183B
| – | – |
-9,832
| Closed | -$552K |
|
1009
Starwood Property Trust
STWD
$5.88B
| – | – |
-118,764
| Closed | -$2.65M |
|
1010
Constellation Brands
STZ
$22.4B
| – | – |
-2,958
| Closed | -$208K |
|
1011
Southwest Gas
SWX
$6.51B
| – | – |
-14,689
| Closed | -$822K |
|
1012
Stryker
SYK
$129B
| – | – |
-17,571
| Closed | -$1.32M |
|
1013
Sysco
SYY
$39.9B
| – | – |
-42,409
| Closed | -$1.53M |
|
1014
Teradyne
TER
$56.7B
| – | – |
-12,495
| Closed | -$220K |
|
1015
Target
TGT
$67.7B
| – | – |
-98,010
| Closed | -$6.2M |
|
|
THS
1016
DELISTED
Treehouse Foods
THS
| – | – |
-41,669
| Closed | -$2.87M |
|
1017
Toll Brothers
TOL
$13.9B
| – | – |
-137,347
| Closed | -$5.08M |
|
1018
Tapestry
TPR
$31.1B
| – | – |
-3,878
| Closed | -$218K |
|
1019
United Airlines
UAL
$41.5B
| – | – |
-69,005
| Closed | -$2.61M |
|
1020
UGI
UGI
$7.78B
| – | – |
-31,380
| Closed | -$867K |
|
1021
Upbound Group
UPBD
$1.15B
| – | – |
-6,788
| Closed | -$226K |
|
1022
United Rentals
URI
$68.8B
| – | – |
-25,377
| Closed | -$1.98M |
|
1023
CALL
Invesco DB US Dollar Index Bullish Fund
UUP
$424M
| – | – |
-2,500
| Closed | -$15K |
|
1024
Wabtec
WAB
$49.9B
| – | – |
-17,325
| Closed | -$1.29M |
|
|
WCC
1025
WESCO International
WCC
$17.5B
| – | – |
-51,111
| Closed | -$4.66M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.